Abstract Guidelines

Opportunity is given for researchers to contribute to the conference via free oral presentations or poster sessions. Abstracts must be submitted online via the abstract submission system before midnight (GMT), 7 July 2017. Abstracts should ONLY be sent via the online submission form available on the website. Abstracts received after this date will NOT be accepted. Abstracts submitted by post, fax or email will NOT be considered.

Whether you wish to present a poster or an oral presentation, you must register for the congress and submit an abstract that needs to be evaluated and approved.

Abstract presentations (oral and poster)

All abstracts should be written, submitted and presented in English with a maximum word count of 250 words (not including the abstract title, authors and institutions).

Authors will be notified in writing by 11 August 2017 as to whether or not their abstract has been accepted for poster presentation. The decision of the Congress Scientific Committee is final and no correspondence will be entered into. Abstracts accepted and presented at the congress will be published, subject to editorial review, in the congress Final Programme book/CD. Once an abstract has been approved, the presenting author must register for the entire congress for final acceptance. The presenting author will benefit Early Bird rates for registration, if abstract is accepted. Non-registered authors may be excluded from publication in the congress Final Programme book/CD.

Instructions for poster presentations are available on the congress website.

All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author, if different

Abstract content guidelines

Abstract submitters should ensure that the version sent is the final one; changes will not be permitted once the deadline has passed.

Institution information should be provided for all authors. Please include institution, city and country, but exclude department, division, laboratory, etc.

  • Authors are required to submit the abstract under one of the congress abstract topics. The abstract topics for the congress are:
  • Stroke
  • Neuro Degenerative Diseases
  • Amputees
  • Brain Trauma
  • Spinal Cord Injuries
  • Musculoskeletal (MSK)
  • Innovative Technology
  • Sociological Aspects
  • Cardio Pulmonary Rehab
  • Geriatrics
  • Sports Rehab
  • other

Abstracts should be structured in four sections as follows:

  • Purpose: Indicate the objectives of the work being presented.
  • Method: Describe study material or subjects (e.g. number and type of patients), intervention and evaluation procedures.
  • Results: Summarize the main findings. Wherever possible, give numerical values and statistical significance or confidence intervals.
  • Conclusion: State briefly the conclusions reached in the work.
  • Acknowledgement: (optional) If the work was supported by funds provided by a commercial organization this should be stated in
    a short acknowledgment at the end of the abstract. Other sources of funding may be acknowledged in the same way.

Figures, tables and other illustrations cannot be included.

Multiple submissions of abstracts describing different components of the same study are not appropriate. All findings generated from the same study should be included in a single abstract.

Abstracts containing single case reports will not usually be accepted, unless the report is of outstanding scientific or clinical interest because of the uniqueness of the findings or the sophistication of the investigations.

Abstracts containing data considered to be insufficiently informative will not be accepted.

Authors should use a concise title that indicates the content of the abstract. Abbreviations should be avoided in the title.

For intervention studies (for example, therapeutic trials), the type of design (prospective or retrospective, controlled or uncontrolled, randomized or observational, open vs. single-blind vs. double-blind), dosages, assessment methods and duration of follow-up should be specified.

Non-proprietary (generic) names of drugs must be used throughout.

Abbreviations should be used sparingly. For words that are abbreviated, use the whole term the first time, followed by the standard abbreviation in parenthesis.

References should be used sparingly. They should be included within the text in brackets. For journals, mention first author “et al” followed by the name of the journal as abbreviated in the Index Medicus, year, volume number and inclusive pages (i.e. Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters, give first author “et al”, editor, title, publisher, city of publication, year and inclusive pages (i.e. Levy RH et al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven, 1996;13-30.).

Submission of an abstract automatically implies acknowledgment that the work described was conducted in accordance with current ethical standards and regulations in biomedical research. Failure to adhere to these standards will result in rejection of the abstract.

Abstract FAQs

Can I make changes to my abstract after submission? You can make changes to the abstract, even if the abstract has been submitted, up to the abstract submission deadline. Once the abstract submission deadline has passed, changes are not permitted unless they relate to the results of the study, in this case only, please contact maltaprma@gmail.com

Can I submit an abstract after the deadline? Late abstracts will not be accepted.

When will I know if my abstract has been accepted? Authors will be notified of their abstracts’ acceptance/rejection by 30 September 2017.

How will I receive the information from the Congress Secretariat? Contact details provided at the time of submission will be used for all correspondence related to the congress. Please ensure that the correct details are entered.

My colleague has received confirmation of his acceptance and I did not, is there something wrong? There may be a problem with your email address, therefore please contact maltaprma@gmail.com